Clinical trials
Phase 1 Breast Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
146 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 7 |
| 2017 | 8 |
| 2018 | 7 |
| 2019 | 7 |
| 2020 | 10 |
| 2021 | 13 |
| 2022 | 19 |
| 2023 | 21 |
| 2024 | 15 |
| 2025 | 19 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
| Recruiting | 41 |
| Unknown status | 30 |
| Active, not recruiting | 13 |
| Not yet recruiting | 7 |
| Terminated | 4 |
| Enrolling by invitation | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sichuan Baili Pharmaceutical Co., Ltd. | 10 |
| Jiangsu HengRui Medicine Co., Ltd. | 8 |
| Peking Union Medical College Hospital | 7 |
| Shandong Suncadia Medicine Co., Ltd. | 5 |
| BeOne Medicines | 4 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 4 |
| Eli Lilly and Company | 4 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 4 |
| Affiliated Hospital of Jiangnan University | 3 |
| Chongqing Precision Biotech Co., Ltd | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 146 |
| Stomach Neoplasms | 22 |
| Ovarian Neoplasms | 21 |
| Lung Neoplasms | 17 |
| Colorectal Neoplasms | 16 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Pancreatic Neoplasms | 12 |
| Prostatic Neoplasms | 11 |
| Esophageal Neoplasms | 9 |
| Neoplasm Metastasis | 9 |
Trials
Showing 1 to 25 of 146. Each trial links to its page on Pharma Observatory.
46 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.